Cambrex invests in formulations firm Zenara
Cambrex buys 51 per cent stake in Indian formulations firm Zenara Pharma, citing efforts to grow in emerging markets as key driver.
Cambrex buys 51 per cent stake in Indian formulations firm Zenara Pharma, citing efforts to grow in emerging markets as key driver.
Inaccurate predictions based on animal models are the biggest cause of clinical failure according to Scottish CRO Biopta, which says use of human tissue samples for preclinical development would cut attrition rates.
Cost cutting measures helped Parexel to one of its most profitable quarters after taking lower-than-expected revenues on project delays and cancellations.
Maccine has opened a dedicated non-human primate (NHP) MRI centre to strengthen its position in translational imaging research services.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Agensys, Unigene, Medivir and Apitope.
Veritas IRB has opened an office in Mexico City in a bid to foster culture of patient safety in expanding central and South American trials sector.